Merck & Company Inc (MRK) Financials

$144.00

$-0.86 (-0.59%)

As on 15-Sep-2026 14:44EDT

Market cap

$357,024 Mln

Revenue (TTM)

$66,400 Mln

P/E Ratio

117.7

P/B Ratio

8.7

Div. Yield

2.3 %

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Operating Revenue	66,400.00	64,926.00	64,168.00	60,115.00	59,283.00	48,704.00
Cost of Revenue	16,350.00	18,195.00	15,193.00	16,126.00	17,411.00	13,626.00
Gross Profit	50,050.00	46,731.00	48,975.00	43,989.00	41,872.00	35,078.00
Operating Expenses	38,994.00	23,245.00	28,754.00	41,035.00	23,590.00	21,879.00
Operating Profit (EBIT)	11,056.00	23,486.00	20,221.00	2,954.00	18,282.00	13,199.00
Other Income	--	--	--	--	-1,501.00	1,341.00
Profit before Tax	5,948.00	21,067.00	19,936.00	1,889.00	16,444.00	13,879.00
Provision for Tax	2,779.00	2,804.00	2,803.00	1,512.00	1,918.00	1,521.00
Profit after Tax (Net Income)	3,173.00	18,254.00	17,117.00	365.00	14,519.00	13,049.00
Minority Interest	4.00	-9.00	-16.00	-13.00	-7.00	691.00
Consolidated Profit	8,748.00	18,254.00	17,117.00	365.00	14,519.00	13,049.00

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Shareholder's Funds	41,933.00	52,606.00	46,313.00	37,581.00	45,991.00	38,184.00
Minority Interest	4.00	--	--	54.00	67.00	73.00
Non-Current Liabilities	60,087.00	55,877.00	42,314.00	43,346.00	38,863.00	43,565.00
Current Liabilities	27,731.00	28,327.00	28,420.00	25,694.00	24,239.00	23,872.00
Total Liabilities	157,533.00	136,866.00	117,106.00	106,675.00	109,160.00	105,694.00

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Non-Current Assets	93,123.00	93,350.00	78,324.00	74,507.00	73,438.00	75,428.00
Current Assets	36,679.00	43,516.00	38,782.00	32,168.00	35,722.00	30,266.00
Total Assets	157,533.00	136,866.00	117,106.00	106,675.00	109,160.00	105,694.00
Total Debt*	53,906.00	50,534.00	38,270.00	36,268.00	31,985.00	34,631.00
Net Current Assets	8,948.00	15,189.00	10,362.00	6,474.00	11,483.00	6,394.00

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Cash From Operating Activities	--	16,472.00	21,468.00	13,006.00	19,095.00	14,109.00
Cash Flow from Investing Activities	--	-13,741.00	-7,734.00	-14,083.00	-4,960.00	-16,555.00
Cash from Financing Activities	--	-1,922.00	-7,032.00	-4,810.00	-9,119.00	2,593.00
Net Cash Inflow / Outflow	--	--	--	--	5,016.00	-202.00

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Adjusted EPS ($)	1.25	7.34	6.74	0.14	5.70	5.15
Cash EPS ($)	--	9.68	8.51	1.63	7.23	6.42
Adjusted Book Value ($)	--	21.14	18.23	14.71	18.05	15.06
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	6.62	8.45	5.09	7.49	5.57
Free Cash Flow per Share ($)	--	4.97	7.12	3.58	5.77	3.81

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
ROCE (%)	--	19.45	21.61	0.48	19.26	19.84
ROE (%)	6.72	36.91	40.81	0.87	34.50	41.10
ROA (%)	2.11	14.37	15.30	0.34	13.52	13.23
EBIT Margin (%)	10.86	34.54	33.05	5.05	29.36	30.15
Net Margin (%)	4.78	28.12	26.68	0.61	25.13	26.07
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Revenue Growth (%)	4.24	0.01	0.07	0.01	0.22	0.17
EBIT Growth (%)	-64.72	5.74	598.75	-82.56	18.53	119.38
Net Profit Growth (%)	-80.62	6.64	4,589.59	-97.49	11.27	84.65
EPS Growth (%)	-80.70	0.09	46.14	-0.97	0.11	0.85
Book Value Growth (%)	-12.99	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Price / Earnings	117.65	14.35	14.77	762.89	19.47	14.89
Price / Book Value	8.68	4.98	5.46	7.41	6.15	5.09
Dividend Yield (%)	2.25	--	--	--	--	--
EV/EBITDA	28.51	10.54	10.79	44.54	14.14	12.34
Close Price ($)	128.50	105.26	99.48	109.02	110.95	76.64
High Price ($)	130.29	107.59	134.63	119.65	112.89	91.40
Low Price ($)	76.66	73.31	94.48	99.14	72.88	68.44
Market Cap ($ Cr)	357,024.43	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Debt to Equity	1.22	0.96	0.83	0.97	0.70	0.91
Short term debt to equity ratio	0.07	0.05	0.06	0.04	0.05	0.07
Current Ratio	1.32	1.54	1.36	1.25	1.47	1.27
Quick Ratio	1.10	1.30	1.15	1.00	1.23	1.02
Interest Coverage	4.41	16.52	16.69	2.65	18.09	18.22

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Debtors to sales (%)	18.92	19.53	16.02	17.22	15.94	18.95
Asset Turnover	0.44	0.51	0.57	0.56	0.55	0.49
Receivable days	--	64.57	58.71	60.15	57.54	60.12
Inventory Days	--	128.14	149.86	138.94	124.44	154.22
Payable days	--	85.14	96.17	92.71	93.07	119.77
Cash Conversion Cycle	--	107.57	112.39	106.39	88.92	94.58

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Income Statement ($ Mln)